Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck
- PMID: 19036528
- DOI: 10.1016/j.ijrobp.2008.09.021
Influence of smoking and alcohol drinking behaviors on treatment outcomes of patients with squamous cell carcinomas of the head and neck
Abstract
Purpose: To retrospectively evaluate the prognostic value of smoking and drinking status in patients with head-and-neck squamous cell carcinomas.
Methods and materials: All patients with all stages and sites were included if complete information was available on baseline smoking and alcohol behavior (never, former, active), disease stage, primary site, radiation dose, sex, and age. Treatment was radiotherapy in 973 patients, postoperative radiotherapy in 469, and chemoradiotherapy in 429. Statistical analysis was performed with Kaplan-Meier and Cox methods.
Results: Data from 1,871 patients were available. At baseline, 9% of patients never smoked, 40% were former smokers, and 51% were active smokers; 20% never drank, 25% were former drinkers, and 55% were active drinkers. Smoking was associated with inferior local control and survival. For local control, the hazard ratio (HR) of active smokers vs. former smokers was 1.5 (p = 0.0001). For survival, the HRs of former smokers and active smokers vs. those who never smoked were also statistically significant (1.3 and 1.7, respectively, p = 0.000001). Alcohol drinking was associated with local control (p = 0.03), and was associated with survival. For survival, HRs of former and active drinkers compared with those who never drank were, respectively, 1.1 (p = 0.01) and 1.28 (p = 0.001). Adjusted 5-year local control and survival rates for those who never smoked and never drank were 87% and 77%, respectively, and for those who were both active smokers and active drinkers were 72% (p = 0.007) and 52% (p = 0.0009), respectively.
Conclusion: Smoking and drinking at baseline were associated with poor outcomes in these patients.
Similar articles
-
Matched-pair analysis of survival of never smokers and ever smokers with squamous cell carcinoma of the head and neck.J Clin Oncol. 2004 Oct 1;22(19):3981-8. doi: 10.1200/JCO.2004.02.133. J Clin Oncol. 2004. PMID: 15459221
-
Randomized phase III trial of low-dose isotretinoin for prevention of second primary tumors in stage I and II head and neck cancer patients.J Natl Cancer Inst. 2006 Apr 5;98(7):441-50. doi: 10.1093/jnci/djj091. J Natl Cancer Inst. 2006. PMID: 16595780 Clinical Trial.
-
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.Cancer Epidemiol Biomarkers Prev. 2001 Aug;10(8):823-9. Cancer Epidemiol Biomarkers Prev. 2001. PMID: 11489748 Clinical Trial.
-
Expanding role of the medical oncologist in the management of head and neck cancer.CA Cancer J Clin. 2008 Jan-Feb;58(1):32-53. doi: 10.3322/CA.2007.0004. Epub 2007 Dec 20. CA Cancer J Clin. 2008. PMID: 18096865 Review.
-
[Epidemiology of head and neck carcinomas].Cancer Radiother. 2005 Feb;9(1):1-7. doi: 10.1016/j.canrad.2004.11.004. Epub 2005 Jan 18. Cancer Radiother. 2005. PMID: 15804614 Review. French.
Cited by
-
Advancements in Hyperspectral Imaging and Computer-Aided Diagnostic Methods for the Enhanced Detection and Diagnosis of Head and Neck Cancer.Biomedicines. 2024 Oct 11;12(10):2315. doi: 10.3390/biomedicines12102315. Biomedicines. 2024. PMID: 39457627 Free PMC article. Review.
-
A radiobiological perspective on radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma.Rep Pract Oncol Radiother. 2024 Feb 16;28(6):809-822. doi: 10.5603/rpor.99355. eCollection 2023. Rep Pract Oncol Radiother. 2024. PMID: 38515813 Free PMC article. Review.
-
Radioresistance or/and radiosensitivity of head and neck squamous cell carcinoma: biological angle.Oral Maxillofac Surg. 2024 Jun;28(2):547-555. doi: 10.1007/s10006-023-01189-9. Epub 2023 Nov 8. Oral Maxillofac Surg. 2024. PMID: 37935817 Review.
-
Negative Prognostic Impact of Smoking on Long-term Survival in Patients With Nasopharyngeal Carcinoma Treated With Curative (Chemo)radiotherapy.In Vivo. 2023 Jul-Aug;37(4):1775-1785. doi: 10.21873/invivo.13266. In Vivo. 2023. PMID: 37369456 Free PMC article.
-
Health behaviors among head and neck cancer survivors.J Health Popul Nutr. 2023 May 29;42(1):48. doi: 10.1186/s41043-023-00390-6. J Health Popul Nutr. 2023. PMID: 37248541 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
